Our 2025 Impact Report is Live — See what we are building together >

Search

Amgen Joins with LabCentral to Support Life-Sciences and Biotech Startups in Cambridge, Massachusetts

Read More

Unum Therapeutics Announces Start of First Phase I Clinical Trial of Cellular Immunotherapy Targeting CD20+ Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Massachusetts Life Sciences Center Announces New Appointee to Board of Directors

Read More

Conkwest Announces $50m in Strategic Investments and Appoints NantWorks Founder, Dr. Patrick Soon-Shiong as Co-Chairman of the Board

Affinivax Announces Collaboration with PATH to Advance the Company’s Lead Vaccine Candidate for Pneumococcal Disease

X-Chem and Navitor Pharmaceuticals Enter into License Agreement on Novel Small Molecules Targeting mTORC1 Activation

Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics

Unum Therapeutics Announces $65 Million Series B Financing Round

XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders

New Commitments in Support of the President’s Nation of Makers Initiative